Plaintiff Melton W. and his wife, Lindsay W. have filed a toe amputation surgery lawsuit against the drug makers claiming that after Melton began taking Invokana for this type-2 diabetes, he suffered problems that led to toe amputation surgery.

His wife is also filing this toe amputation surgery lawsuit on counts of loss of consortium.

Melton began taking Invokana in 2015 to treat his type-2 diabetes. He claims that he “had several alternative and safer methods to treat his diabetes, including diet and exercise and other diabetes medications,” yet was prescribed Invokana regardless.

According to this toe amputation surgery lawsuit, when Melton was prescribed Invokana, he was supposed to take it once by mouth once a day to “improve glycemic control.” It was intended that he would take this in addition to proper diet and exercise.

However, in 2016, he claims as a direct result of taking Invokana, Melton developed diabetic ulcers on both of his feet. Because of this, he began to undergo wound care treatment for these diabetic ulcers.

In March 2017, as a result of taking Invokana, this toe amputation surgery lawsuit claims, Melton was forced to undergo toe amputation surgery. His great right toe, his right second toe, and his left little toe were all amputated, allegedly as a result of taking Invokana.

He claims that his pain is constant and that his mobility has been severely limited because of these Invokana-caused injuries. His wife, Lindsay, must now assist him when he performs regular daily activities and he is limited to staying at his home.

His toe amputation surgery lawsuit claims that Melton “has endured pain and suffering, and will continue to endure pain and suffering as a result of his permanent disability, as well as emotional distress, loss of enjoyment of life, and economic loss, including significant past and future expenses for medical care and treatment.”

The plaintiff believes that his injuries were preventable and that they resulted because Janssen failed to conduct proper safety studies and that when they did understand that there may be problems with their drug, they failed to let the medical community and public know about the safety signals. He alleges that Janssen participated in “suppression of information” that would have revealed life-threatening and debilitating risks and that they willfully and wantonly failed to provide proper instructions for use.

He believes that Janssen should have warned his doctors about the potential risks of diabetic ketoacidosis, renal failure, and sepsis. These can cause other dangerous conditions such as gangrene, diabetic foot ulcers lower limb ischemia and the need for toe amputation surgery.

In addition, if he would have known about the dangers associated with Invokana use, Melton claims, he would have never agreed to begin taking it to treat his type-2 diabetes.

This Toe Amputation Surgery Lawsuit is Case No. 3:18-cv-02457-BRM-LHG in the United States District Court for the District of New Jersey.